The European Pharmacopoeia Commission has released the new version of chapter 2.6.7 (Edition 12.2), which will become effective in April 2026.
This update marks a major milestone in mycoplasma testing compliance, as PCR-based mycoplasma detection methods are now officially recognized as fully equivalent to traditional culture assays.
With a defined detection limit of 10 colony-forming units per ml (10 CFU/ml) or less than 100 genomic copies per ml (100 GC/ml), the new regulation sets a clear benchmark for nucleic acid amplification techniques (NAT) based mycoplasma testing and confirms the central role of molecular methods in future quality control and contamination detection.
|